Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC)

Immune checkpoint inhibition (ICI) of the PD-1/PD-L1 axis shows durable responses in a subset of patients with metastatic urothelial carcinoma (UC). However, PD-L1 expression in tumor biopsies does not necessarily correlate with response to PD-1/PD-L1 inhibitors. Thus, a reliable predictive biomarke...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergmann, Sonja, Coym, Anja, Ott, Leonie, Soave, Armin, Rink, Michael, Janning, Melanie, Stoupiec, Malgorzata, Coith, Cornelia, Peine, Sven, von Amsberg, Gunhild, Pantel, Klaus, Riethdorf, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199812/
https://www.ncbi.nlm.nih.gov/pubmed/32391189
http://dx.doi.org/10.1080/2162402X.2020.1738798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199812/
https://www.ncbi.nlm.nih.gov/pubmed/32391189
http://dx.doi.org/10.1080/2162402X.2020.1738798

Ejemplares similares